JUL 08, 2020 11:55 AM PDT

Scientists Use Genetics to Control Regulatory T Cells

WRITTEN BY: Kara Marker

The ability to control regulatory T cells of the immune system has long been sought out by scientists, especially those with vested interests in improving treatments for autoimmune disease and cancer. In autoimmune disease, the immune system is overreacting to a stimulus that shouldn’t elicit such a response, and in cases of cancer, the immune system needs a bit of a push to identify, target, and eliminate cancerous cells. If you control the regulatory T cells (Tregs), you can control the immune response.

Researchers from the Salk Institute already had one gene on their radar: Foxp3. They had discovered in past studies that Foxp3 was deeply connected to Treg development and function; Foxp3 is a vital part of the puzzle for the structure and production of Treg activity.

In their new study, researchers used CRISPR gene-editing technology to test and identify additional gene candidates for involvement Treg function, looking for connections to Foxp3. They preliminarily identified hundreds of gene candidates as a result of the screening process. They narrowed down their exploration to focus on a select group of genes that involved with the “SWI/SNF complex.”

The SWI/SNF complex is a group of proteins involved in activating and deactivating genes by acting as gatekeepers for DNA that need to reach necessary cellular machinery. Next in the study, researchers tested to see what happens when SWI/SNF complex genes are removed from Tregs. One gene from a specific complex called ncBAF, Brd9, when deleted, led to lower levels of Foxp3 and weakened function in Tregs.

In mice models of cancer, Brd9-deficient Treg treatments prompted the activity of immune cells normally inhibited by Tregs to target cancerous growth. However, in mice models of inflammatory bowel disease, the deficient Tregs had a negative effect, failing to diminish the autoimmune attack on the digestive tract.

With a new tool for the selective tuning of Treg function, researchers are one step closer to being able to target specific conditions with precision, i.e. a specific autoimmune disorder or specific tissues affected by cancer.

Sources: Salk Institute, Immunity

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
OCT 07, 2021
Cancer
Dual Threat: CAR T Cells Modified to Target Two Neuroblastoma Antigens
OCT 07, 2021
Dual Threat: CAR T Cells Modified to Target Two Neuroblastoma Antigens
Neuroblastoma is a cancer of immature nerve cells found in various areas, including the adrenal glands, neck, chest ...
OCT 14, 2021
Immunology
'Bio-Betters' Form the Next Wave of Cancer Therapies
OCT 14, 2021
'Bio-Betters' Form the Next Wave of Cancer Therapies
  Antibodies are blood proteins with highly specialized functions: to recognize and eliminate bacteria, viruses, an ...
NOV 04, 2021
Immunology
The Coronavirus Infects Inner Ear Cells
NOV 04, 2021
The Coronavirus Infects Inner Ear Cells
An increasing number of COVID-19 patients have reported ear-related issues: ringing in the ear, hearing loss, and balanc ...
NOV 09, 2021
Immunology
Wikipedia, but Make It Immune Cells
NOV 09, 2021
Wikipedia, but Make It Immune Cells
Scientists have established the first searchable database of complex immune data, providing the foundations for a new er ...
NOV 25, 2021
Immunology
What's a T Cell COVID Vaccine and Could It Be Better Than What We Have?
NOV 25, 2021
What's a T Cell COVID Vaccine and Could It Be Better Than What We Have?
All vaccines train the immune system to recognize and wage war against pathogens such as viruses and bacteria. However, ...
DEC 30, 2021
Cell & Molecular Biology
Researchers Discover Immune Cell Subtype Linked to MS and Neuroinflammation
DEC 30, 2021
Researchers Discover Immune Cell Subtype Linked to MS and Neuroinflammation
We still don't know exactly what causes multiple sclerosis (MS), or many other disorders that involve inflammation in th ...
Loading Comments...